| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/04/2011 | CA2548165C Process for purifying interferon beta |
| 10/04/2011 | CA2521038C Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production |
| 10/04/2011 | CA2431199C Immunotherapeutic kit for the treatment of tumors |
| 10/04/2011 | CA2339850C A non-cytolytic recombinant hiv-1 vaccine |
| 10/04/2011 | CA2338886C Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 10/04/2011 | CA2285658C Direct expression of peptides into culture media |
| 10/04/2011 | CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 10/04/2011 | CA1341622C Insect resistant plants |
| 09/29/2011 | WO2011120013A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof |
| 09/29/2011 | WO2011119906A1 HUMAN POLYOMAVIRUS 6 (HPyV6) AND HUMAN POLYOMAVIRUS 7 (HPyV7) |
| 09/29/2011 | WO2011119724A2 Colorimetric and fluorescent proteins |
| 09/29/2011 | WO2011119716A2 Flavivirus host range mutations and uses thereof |
| 09/29/2011 | WO2011119657A1 Novel peptides and methods for their preparation and use |
| 09/29/2011 | WO2011119628A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 09/29/2011 | WO2011119174A1 Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 09/29/2011 | WO2011119115A1 Method of producing recombinant proteins with mannose- terminated n-glycans |
| 09/29/2011 | WO2011118954A9 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells |
| 09/29/2011 | WO2011118954A2 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells |
| 09/29/2011 | WO2011118779A1 Pharmaceutical composition for treatment and prevention of herpesvirus infections |
| 09/29/2011 | WO2011118699A1 Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand |
| 09/29/2011 | WO2011118682A1 Aptamer for ngf and use thereof |
| 09/29/2011 | WO2011117839A1 Bacillus pumilus bilirubin oxidase and applications thereof |
| 09/29/2011 | WO2011117583A2 Method |
| 09/29/2011 | WO2011117582A1 Dendritic cell inhibitory proteins from ticks |
| 09/29/2011 | WO2011117417A1 Novel glucagon analogues |
| 09/29/2011 | WO2011117416A1 Novel glucagon analogues |
| 09/29/2011 | WO2011117415A1 Novel glucagon analogues |
| 09/29/2011 | WO2011117352A1 Primate model from the family cercopithecidae infected by a hbv strain of human genotype |
| 09/29/2011 | WO2011116974A2 Adenovirus derived helper virus for enhancing recombinant parvovirus production |
| 09/29/2011 | WO2011116655A1 Antigen for increasing cd4+cd25+foxp3+ regulatory t cells and uses thereof |
| 09/29/2011 | WO2011116456A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 09/29/2011 | WO2011116411A1 Salt-resistant emulsions |
| 09/29/2011 | WO2011087642A3 Novel bacillus thuringiensis gene with coleopteran activity |
| 09/29/2011 | WO2011080267A3 Gh61 polypeptides having detergency enhancing effect |
| 09/29/2011 | WO2011070214A8 Conjugates and compositions for immunotherapy and anti-tumor treatment |
| 09/29/2011 | WO2011068792A3 Compositions and methods for making and using bone marrow mesenchymal stem cells and erythroid progenitor cells |
| 09/29/2011 | WO2011048353A3 Construct for production of empty picornaviral capsids |
| 09/29/2011 | WO2011043823A3 Polypeptides that home to atherosclerotic plaque |
| 09/29/2011 | WO2011004263A3 Conserved escherichia coli immunogens |
| 09/29/2011 | WO2010132370A3 Soluble tlt-1 for the treatment and diagnosis of sepsis |
| 09/29/2011 | WO2007127841A3 Compositions and methods of preparation thereof |
| 09/29/2011 | US20110239334 Nematode-resistant plants, and modified bacillus thuringiensis cry genes and proteins |
| 09/29/2011 | US20110239331 Insecticidal Compounds and Methods for Selection Thereof |
| 09/29/2011 | US20110239328 SWEETPOTATO SRD1 cDNA AND TRANSGENIC PLANTS WITH HIGH-NUMBERED STORAGE ROOTS USING THE SAME |
| 09/29/2011 | US20110239320 Soybean variety d5624041 |
| 09/29/2011 | US20110239317 Polynucleotides encoding promyostatin polypeptides |
| 09/29/2011 | US20110239311 Agonists of NR2F6 For Immunosupression |
| 09/29/2011 | US20110237782 Methods for glyco-engineering plant cells for controlled human o-glycosylation |
| 09/29/2011 | US20110237778 Process for the extraction of macromolecules from a biomass using thin stillage |
| 09/29/2011 | US20110237775 Methods for characterizing glycoproteins and generating antibodies for same |
| 09/29/2011 | US20110237688 Methods and compositions related to acetylocholine receptor conjugates |
| 09/29/2011 | US20110237657 Transport-Mediating Colloidal Pharmaceutical Compounds |
| 09/29/2011 | US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 09/29/2011 | US20110237523 CONTRACEPTIVE PEPTIDES DERIVED FROM THE VENOM OF THE SPIDER Latrodectus mirabilis, NUCLEOTIDE SEQUENCES TO TRANSFORM A MICROORGANISM TO PRODUCE SAID PEPTIDES; METHODS TO OBTAIN THE PEPTIDES; PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USE THEREOF |
| 09/29/2011 | US20110237518 Method for treating or preventing bladder cancer using the depdc1 polypeptide |
| 09/29/2011 | US20110237509 hGH AND METHODS FOR PREPARING hGH |
| 09/29/2011 | US20110237507 Methods of protecting against apoptosis using lipopeptides |
| 09/29/2011 | US20110237506 Protein stabilization formulations |
| 09/29/2011 | US20110237503 Novel peptides and methods for their preparation and use |
| 09/29/2011 | US20110237502 Insecticidal Polypeptides and Methods of Use Thereof |
| 09/29/2011 | US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| 09/29/2011 | US20110237485 Chrysosporium Cellulase and Methods of Use |
| 09/29/2011 | US20110237484 Electrochemical textile-washing process |
| 09/29/2011 | US20110237451 Competitive n-hybrid system |
| 09/29/2011 | US20110236975 Growth factor which acts through erb b-4 rtk |
| 09/29/2011 | US20110236973 Centrosome proteins and uses thereof |
| 09/29/2011 | US20110236953 EMBRYONIC CEREBROSPINAL FLUID (e-CSF), PROTEINS FROM e-CSF, AND RELATED METHODS AND COMPOSITIONS |
| 09/29/2011 | US20110236952 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof |
| 09/29/2011 | US20110236931 Chemical and biochemical adducts as biomarkers for organophosphate exposure |
| 09/29/2011 | US20110236925 Method of Obtaining a Purified, Biologically Active Heterologous Protein |
| 09/29/2011 | US20110236910 Prostate cancer biomarker |
| 09/29/2011 | US20110236900 Novel muts protein and method for determing mutation using the same |
| 09/29/2011 | US20110236897 Novel markers for diagnosing brain disease caused by brain injury and use thereof |
| 09/29/2011 | US20110236886 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 09/29/2011 | US20110236556 Production of soluble protein solutions from soy ("s701") |
| 09/29/2011 | US20110236554 Hydrolysed protein-polysaccharide complexes |
| 09/29/2011 | US20110236484 Genus-Wide Chlamydial Peptide Vaccine Antigens |
| 09/29/2011 | US20110236483 Rna vector therapy |
| 09/29/2011 | US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/29/2011 | US20110236467 Method for erectile function potentiation by pharmaceutical compositions comprising toxin tx2-6 of the spider phoneutria nigriventer |
| 09/29/2011 | US20110236455 Novel Regulators of the Innate Immune System |
| 09/29/2011 | US20110236421 Flavivirus host range mutations and uses thereof |
| 09/29/2011 | US20110236420 Bluetongue virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236416 Foot and mouth disease virus recombinant vaccines and uses thereof |
| 09/29/2011 | US20110236410 Klebsiella antigens |
| 09/29/2011 | US20110236407 Vaccine for runting-stunting syndrome |
| 09/29/2011 | US20110236404 Methods for Protein Expression in Mammalian Cells in Serum-Free Medium |
| 09/29/2011 | US20110236397 Limited proteolysis of cd2ap and progression of renal disease |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236385 Blocking mesothelin peptide fragments |
| 09/29/2011 | US20110236371 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions |
| 09/29/2011 | US20110236359 Antimicrobial Activity of Bacteriocin-Producing Lactic Acid Bacteria |
| 09/29/2011 | US20110236353 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 09/29/2011 | US20110236314 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 09/29/2011 | DE19641876B4 Streptavidinmuteine Streptavidin muteins |
| 09/29/2011 | DE112009001667T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same |
| 09/29/2011 | DE112009001459T5 Pflanzen mit gesteigerten ertragsbezogenen Eigenschaften und Verfahren zur Herstellung derselben Plants having enhanced yield-related traits and methods of making the same |
| 09/29/2011 | DE102005008416B4 Verfahren zur Reinigung von marinem Kollagen A method for purifying marine collagen |
| 09/29/2011 | CA2830687A1 Salt-resistant emulsions |
| 09/29/2011 | CA2794664A1 Novel peptides and methods for their preparation and use |